Here are five health companies Intel is investing in:
- Intel Capital recently led a $20 million funding round for MDI Health, a medication management company using artificial intelligence.
- In August 2022, Intel Capital joined in a $320 million series D financing round for virtual care and digital medicine company Biofourmis.
- In January 2022, the company joined in a $15 million series A financing round for VeriSIM Life, a company that uses artificial intelligence to predict clinical outcomes.
- Intel Capital invested in health information services and devices company Exo in August 2021.
- Intel Capital joined in a $105 million series B financing round for gene therapy company Senti Bio in January 2021.
